Science is built on collaboration, partnership, sharing and ideas. Science can solve some of the world’s most complex problems, but only when the best ideas are brought together. Johnson & Johnson Innovation is proud to support “Together Science Can” – a new campaign to celebrate and fuel scientific collaboration.
A new generation of medical device technologies is spurring incredible progress across the health care spectrum, from enabling non-invasive surgeries to signaling serious health problems before they begin to impact patients’ lives.
For Breakthrough Innovation, Follow the Big Needs not the Existing Solutions
In healthcare, what really drives large-scale advances in patient care, access to therapies and economic value are approaches which are needs-based as opposed to technology-driven. Investing time and effort to understand those needs which have the greatest impact on clinical outcomes, economic value and customer satisfaction, and seeking out the best solutions regardless of their source is what truly moves the innovation needle – particularly in medical devices.
Mentorship Is Nice, But Sponsorship Changes the Game
What does it really take to turn the tides of diversity in the life sciences?
Some people say it’s about being more diligent in recruiting rather than relying on “tried and true” networks. Others say the secret is pairing young women and minorities with executive-level mentors who can lead by example.
JJDC and Janssen Immunology invest in BiomX, a pioneering microbiome therapeutics company
The microbiome represents a dramatically new frontier of medicine, with advances occurring in parallel across many modalities and disease areas. Underscoring the vast potential in this field, JJDC co-led an investment with Janssen Immunology and its IBD team in BiomX, Ltd., a pioneering microbiome therapeutics company.
Date or reference or blank 5 June 2017